Dongwha Pharm.Co.,Ltd (KRX:000020)

Dongwha Pharm.Co.,Ltd Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	428,482	361,109	340,426	293,018	272,075	307,150
Other Revenue	-	-	-0	-	-	-
Revenue	428,482	361,109	340,426	293,018	272,075	307,150
Revenue Growth (YoY)	18.59%	6.08%	16.18%	7.70%	-11.42%	0.18%
Cost of Revenue	222,498	170,693	159,436	143,671	133,409	185,554
Gross Profit	205,984	190,416	180,990	149,347	138,666	121,596
Selling, General & Admin	164,251	142,338	125,515	103,217	92,288	89,486
Research & Development	21,583	21,548	19,285	17,338	16,912	16,332
Other Operating Expenses	2,433	2,291	1,993	1,808	1,930	1,713
Operating Expenses	197,092	171,750	151,075	126,848	115,588	112,081
Operating Income	8,892	18,666	29,915	22,499	23,078	9,516
Interest Expense	-1,661	-308.01	-370	-383.11	-292.15	-206.96
Interest & Investment Income	3,231	6,683	2,493	1,744	1,840	1,943
Earnings From Equity Investments	147.78	2,420	-2,269	-410.4	-114.11	6,085
Currency Exchange Gain (Loss)	-329.26	377.78	31.87	687.36	-499.17	-6.93
Other Non Operating Income (Expenses)	325.74	145.65	527.55	630.9	-357.6	-980.12
EBT Excluding Unusual Items	10,607	27,985	30,328	24,768	23,655	16,349
Gain (Loss) on Sale of Investments	-149.01	9,434	-4,506	1,801	2,561	-175.67
Gain (Loss) on Sale of Assets	33.17	28.76	741.89	169.46	7,462	-2.89
Asset Writedown	-671.48	-491.98	-3,478	-316.08	-39.91	70
Other Unusual Items	-	-	-	105.41	-	-
Pretax Income	9,819	36,956	23,086	26,527	33,638	16,241
Income Tax Expense	4,269	8,719	1,494	6,944	4,923	7,133
Earnings From Continuing Operations	5,550	28,237	21,591	19,583	28,715	9,108
Minority Interest in Earnings	2,123	-798.76	-1,208	-1,712	-207.41	8.38
Net Income	7,673	27,438	20,383	17,870	28,508	9,116
Net Income to Common	7,673	27,438	20,383	17,870	28,508	9,116
Net Income Growth	-73.68%	34.61%	14.06%	-37.31%	212.72%	-9.46%
Shares Outstanding (Basic)	28	28	28	28	28	28
Shares Outstanding (Diluted)	28	28	28	28	28	28
Shares Change (YoY)	0.13%	0.02%	0.16%	0.05%	0.05%	-
EPS (Basic)	276.85	991.07	736.42	646.68	1032.60	330.20
EPS (Diluted)	276.85	991.07	736.42	646.68	1032.51	330.00
EPS Growth	-73.72%	34.58%	13.88%	-37.37%	212.88%	-9.51%
Free Cash Flow	-41,435	4,626	10,792	14,087	17,982	8,488
Free Cash Flow Per Share	-1495.07	167.09	389.91	509.78	651.02	307.44
Dividend Per Share	180.000	180.000	180.000	180.000	180.000	-
Gross Margin	48.07%	52.73%	53.17%	50.97%	50.97%	39.59%
Operating Margin	2.08%	5.17%	8.79%	7.68%	8.48%	3.10%
Profit Margin	1.79%	7.60%	5.99%	6.10%	10.48%	2.97%
Free Cash Flow Margin	-9.67%	1.28%	3.17%	4.81%	6.61%	2.76%
EBITDA	27,265	32,562	42,424	34,591	33,785	21,000
EBITDA Margin	6.36%	9.02%	12.46%	11.81%	12.42%	6.84%
D&A For EBITDA	18,373	13,896	12,509	12,093	10,707	11,485
EBIT	8,892	18,666	29,915	22,499	23,078	9,516
EBIT Margin	2.08%	5.17%	8.79%	7.68%	8.48%	3.10%
Effective Tax Rate	43.48%	23.59%	6.47%	26.18%	14.64%	43.92%
Advertising Expenses	-	41,140	34,455	29,889	27,532	29,163

Source: S&P Capital IQ. Standard template. Financial Sources.